GSK
22 pharma companies join forces for global non-communicable disease initiative
January 18, 2017Research and Development BMS, Celgene, Eisai, Eli Lilly, GSK, J&J, JJ, MSD, Merck, Novartis, Pfizer, Roche, Sanofi, Takeda
The World Economic Forum Annual Meeting in Switzerland has seen the launch of Access Accelerated, a global initiative consisting of …
NICE recommends GSK’s “first-in-class” asthma drug
November 30, 2016Sales and Marketing GSK, NICE, Nucala, asthma
NICE has announced its recommendation of GSK’s “first-in-class” biologic Nucala (mepolizumab) as an extra option for the treatment of adults …
GSK applies for EU approval for shingles vaccine
November 28, 2016Sales and Marketing European Commission, GSK, GlaxoSmithKline, Shingrix, shingles
After filing for FDA approval in October, GlaxoSmithKline has now applied for approval from the European Commission (EC) for its …
GSK reaches endgame of race to develop anaemia drug
November 25, 2016Research and Development, Sales and Marketing AstraZeneca, Daprodustat, GSK, GlaxoSmithKline, anaemia
GlaxoSmithKline has announced that they will begin Phase 3 development of their anaemia drug, daprodustat. The drug is an oral …
GSK 18 months ahead of the game with three-drug inhaler
November 21, 2016Medical Communications, Sales and Marketing GSK, Innoviva, chronic obstructive pulmonary disease
GlaxoSmithKline, alongside its partner Innoviva, have filed a regulatory submission with the FDA for its treatment for chronic obstructive pulmonary …
GSK/J&J release how their drug measures up against Humira
November 18, 2016Medical Communications, Research and Development GSK, Humira, Janssen, Johnson & Johnson, sirukumab
GlaxoSmithKline and Janssen, part of Johnson & Johnson, released the results of their two Phase III trials exploring treatment options …
GSK emerges top of the pile for improving access to medicine
November 14, 2016Medical Communications, Sales and Marketing Access to Medicine Index, GSK, market access, pricing
GlaxoSmithKline, the British drugmaker, has topped the overall ranking of the Access to Medicine Index, which ranks 20 top pharmaceutical …
FDA clears digital sensor for GSK inhaler
November 8, 2016Manufacturing and Production, Sales and Marketing FDA, GSK, GlaxoSmithKline, Propeller Health, ellipta
The FDA has given 510(k) clearance to a smart inhaler sensor developed by Propeller Health for use with GlaxoSmithKline’s Ellipta …
GSK applies for FDA approval for shingles vaccine
October 24, 2016Sales and Marketing GSK, GlaxoSmithKline, Vaccine, chickenpox, shingles
GlaxoSmithKlien, the UK’s biggest drugmaker, is seeking approval from the FDA for a shingles (herpes zoster) vaccine. The vaccine would …
Cancer Research UK receives ‘success payment’ from GlaxoSmithKline
October 7, 2016Medical Communications GSK, GlaxoSmithKline, University of Manchester, cancer research
CRT and the University of Manchester were rewarded financially for their collaboration developing molecules targeting cancer epigenetics. The agreement between …
GSK agrees to $20m settlement for Chinese bribery allegation
October 3, 2016Business Services, Sales and Marketing China, GSK, GlaxoSmithKline
GlaxoSmithKline has agreed to settle a bribery allegation in China with a payment of $20 million to the US Securities …
GSK appoints Emma Walmsley as first female CEO
September 21, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, appointment
GlaxoSmithKline, the UK’s biggest drugs company, has appointed Emma Walmsley as its new CEO. Walmsley will step into the vacancy …
GSK appoints Emma Walmsley as CEO
September 20, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, appointment
GlaxoSmithKline, the UK’s biggest drugs company, has appointed Emma Walmsley as its new CEO. Walmsley will step into the vacancy …
Top Ten articles in the Pharma Industry this week
September 16, 2016Medical Communications Bayer, GSK, Gilead, GlaxoSmithKline, J&J, JJ, Pfizer, Roche, Sanofi, Takeda, aspen, google, monsanto
As we come to the end of another week, we’re looking back at an exciting week in the industry; there …
GSK and J&J file rheumatoid arthritis treatment sirukumab in EU
September 13, 2016Manufacturing and Production, Sales and Marketing GSK, GlaxoSmithKline, Johnson & Johnson, rheumatoid arthritis, sarilumab, sirukumab
GlaxoSmithKline and partner Johnson & Johnson’s Janssen Biologics unit have filed for approval of rheumatoid arthritis (RA) treatment sirukumab in …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
